NCT01809574

Brief Summary

We hypothesized that the multi-disciplinary assessment of interstitial lung disease patients would lead to a more accurate diagnosis and consequently alterations in treatment regimens that may lead to improved outcomes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2013

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 10, 2013

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 12, 2013

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2013

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2016

Completed
Last Updated

April 9, 2015

Status Verified

October 1, 2013

Enrollment Period

2.8 years

First QC Date

March 10, 2013

Last Update Submit

April 8, 2015

Conditions

Interstitial Lung DiseaseIdiopathic Pulmonary FibrosisConnective Tissue Disease

Keywords

Interstitial lung diseaseIdiopathic pulmonary fibrosisConnective tissue disease

Outcome Measures

Primary Outcomes (1)

  • The number of patients with collagen related pulmonary fibrosis that are diagnosed by Rheumatologists compared to Pulmonologists.

    two years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

60 patients that will refer to the pulmonary outpatient or inpatients department for evaluation due to ILD will be included

You may qualify if:

  • Age above 18 years old
  • ILD according to ATS/ERS guidelines
  • Signed inform consent

You may not qualify if:

  • Previous lung surgery
  • Other significant systemic disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Meir Medical Center

Kfar Saba, Israel, 972, Israel

RECRUITING

MeSH Terms

Conditions

Lung Diseases, InterstitialIdiopathic Pulmonary FibrosisConnective Tissue Diseases

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesPulmonary FibrosisSkin and Connective Tissue Diseases

Study Officials

  • David Shitrit, Dr

    Head of Pulmonary departmant, Meir Medical Center.

    PRINCIPAL INVESTIGATOR

Central Study Contacts

David Shitrit, Dr.

CONTACT

097471556davids3@clalit.org.il

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 10, 2013

First Posted

March 12, 2013

Study Start

May 1, 2013

Primary Completion

March 1, 2016

Study Completion

March 1, 2016

Last Updated

April 9, 2015

Record last verified: 2013-10

Locations

IL(1)